SCHEMBL15813909

SCHEMBL15813909

C[N+](C)(C)CC(CC(=O)O)OC(=O)CC(O)C(=O)[O-]

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.57
▸ SMN1; SMN2 Q16637 1/20 0.57
▸ CYP1A2 P05177 4/20 0.56
▸ MEN1 O00255 5/20 0.55
▸ KMT2A Q03164 5/20 0.55
▸ MAPK1 P28482 4/20 0.55
▸ MAPT P10636 4/20 0.55
▸ GMNN O75496 3/20 0.55
▸ NPSR1 Q6W5P4 3/20 0.55
▸ TP53 P04637 3/20 0.55
▸ TSHR P16473 3/20 0.55
▸ HSP90AA1 P07900 2/20 0.55
▸ BLM P54132 2/20 0.55
▸ NR1H4 Q96RI1 2/20 0.55
▸ CYP2C9 P11712 2/20 0.55
▸ HIF1A Q16665 2/20 0.55
▸ CYP2C19 P33261 2/20 0.54
▸ RECQL P46063 1/20 0.54
▸ GLA P06280 1/20 0.54
▸ PMP22 Q01453 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5427277 1.00 LMNA (0.57) LMNASMN1; SMN2CYP1A2MEN1KMT2A
SCHEMBL28581905 0.86 LMNA (0.58) LMNASMN1; SMN2CYP1A2MEN1KMT2A
SCHEMBL27906323 0.86 LMNA (0.58) LMNASMN1; SMN2CYP1A2MEN1KMT2A
SCHEMBL16915065 0.84 LMNA (0.57) LMNASMN1; SMN2CYP1A2MEN1KMT2A
SCHEMBL3193491 0.83 LMNA (0.64) LMNASMN1; SMN2CYP1A2MEN1KMT2A
SCHEMBL5085300 0.83 LMNA (0.55) LMNASMN1; SMN2CYP1A2MEN1KMT2A
SCHEMBL19923321 0.82 LMNA (0.62) LMNASMN1; SMN2CYP1A2MEN1KMT2A
SCHEMBL20742884 0.82 LMNA (0.62) LMNASMN1; SMN2CYP1A2MEN1KMT2A
SCHEMBL28916570 0.82 LMNA (0.62) LMNASMN1; SMN2CYP1A2MEN1KMT2A
SCHEMBL19923320 0.82 LMNA (0.62) LMNASMN1; SMN2CYP1A2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12441959-B2 Composition containing organic ammonium salt MIYOSHI OIL & FAT CO., LTD. (JP) 2025-10-14 — — US disclosed
US-20220098515-A1 COMPOSITION CONTAINING ORGANIC AMMONIUM SALT MIYOSHI OIL & FAT CO., LTD. (JP) 2022-03-31 — — US disclosed
EP-3925672-A1 COMPOSITION CONTAINING ORGANIC AMMONIUM SALT Miyoshi Oil & Fat Co., Ltd. (JP) 2021-12-22 — — EP disclosed
CN-113423800-A Compositions comprising organic ammonium salts 三吉油脂株式会社 2021-09-21 — — CN disclosed
WO-2020166674-A1 COMPOSITION CONTAINING ORGANIC AMMONIUM SALT ミヨシ油脂株式会社 2020-08-20 — — WO disclosed
US-20140178315-A1 Topical Compositions Comprising Ionic Fluids ARCH CHEMICALS, INC. (US) 2014-06-26 — — US disclosed
WO-2014100633-A1 TOPICAL COMPOSITIONS COMPRISING IONIC FLUIDS ARCH CHEMICALS, INC. (US) 2014-06-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12441959-B2 Composition containing organic ammonium salt SLC6A15, SLC38A7, SLC6A19 LMNA 4201/4885SMN1; SMN2 3001/4885CYP1A2 4585/4885
US-20220098515-A1 COMPOSITION CONTAINING ORGANIC AMMONIUM SALT SLC6A15, SLC38A7, SLC6A19 LMNA 4201/4885SMN1; SMN2 3001/4885CYP1A2 4585/4885
US-20140178315-A1 Topical Compositions Comprising Ionic Fluids KRT18, DSG1, AQP1 LMNA 2566/4885SMN1; SMN2 4442/4885CYP1A2 3182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback